Skip to main content

Sexual health patient group direction (PGD) equality impact assessment (EIA)

1 Details

Equality impact assessment details
Detail Answer
Care group or corporate services: Children’s care group
Name of service or title of policy or strategy, name of event:
  • Supply and, or administration of levonorgestrel 1500mg tablet(s) for emergency contraception
  • Supply and, or administration of ulipristal acetate 30mg tablet for emergency contraception
  • Administration of intramuscular (IM) medroxyprogesterone acetate (DMPA) injection
  • Supply of a combined oral hormonal contraceptive (COC)
  • Supply of a progestogen only contraceptive pill (POP)
  • Supply of azithromycin for the treatment of uncomplicated Chlamydia trachomatis, uncomplicated Mycoplasma genitalium and non-gonococcal or non-specific urethritis PGD
  • Supply of combined hormonal contraceptive transdermal patch
  • Supply of combined hormonal contraceptive vaginal ring
  • Supply of doxycycline for the treatment of uncomplicated Chlamydia trachomatis, epididymo-orchitis uncomplicated Mycoplasma genitalium and non-gonococcal or non-specific urethritis PGD
  • Supply and, or administration of subcutaneous medroxyprogesterone acetate (SC-DMPA) injection
  • Administration of ceftriaxone injection (reconstituted with lidocaine 1% w/v injection) by intramuscular (IM) injection for the treatment of uncomplicated Neisseria gonorrhoeae infection PGD
  • Supply of oral metronidazole for the treatment of Bacterial Vaginosis (BV) or Trichomonas vaginalis (TV) PGD
  • Insertion of the Progestogen-Only Intra-Uterine System (IUS)
  • Administration of lidocaine hydrochloride 1% injection to facilitate insertion and, or removal of subdermal etonogestrel (for example, Nexplanon) implant
  • Insertion of etonogestrel (for example, Nexplanon) 68mg subdermal implant for contraception
  • Supply of clotrimazole 1% cream for the symptomatic relief of vulvo-vaginal candidiasis PGD
  • Supply of clotrimazole 500mg pessary for the treatment of vulvo-vaginal candidiasis PGD
  • Supply of fluconazole 150mg capsule for the treatment of vulvo-vaginal candidiasis PGD
  • Supply of imiquimod 5% w/w cream for the treatment of external anogenital warts
  • Supply of oral aciclovir for the treatment of genital herpes simplex virus (HSV) infections
  • Supply of podophyllotoxin 0.15% w/w cream or 0.5% w/v solution for the treatment of external anogenital warts
Equality impact assessment undertaken by: Tina Proctor, Nurse Consultant TriHealth
Type: Policy
Date: 21 September 2021

2 Questions

2.1 What are the main aims and purposes of the policy, service, or strategy or event

To allow registered nurses who are trained, to supply and administrator sexual health medication within the trust.

2.2 Who is involved in delivering the service, implementing the policy, strategy or organising the event

Registered nurses.

2.3 What information, data or experience can you draw on to provide an indication of the potential inclusive or exclusive results of delivering this service or event or implementing the policy or strategy

The PGD’s follow the guidelines, which have been written by British Association for Sexual Health and HIV (BASHH). Also follow’s service standards written by them and the trust policy.

Impact on different groups
Protected characteristics Impact Evidence for impact
Age Positive All patients under the age of 16yrs are assessed for Fraser competency. The PGD’s are used by both Tri-Health (19 years and over) and Project 3 (18 years and under)
Disability Positive Individuals are assessed on their need for the medication. All couches are able to be at correct height to aid access on to couch. Lift in building
Gender reassignment Positive Individuals are assessed on their need or individual basis
Marriage and civil partnership Positive The PGD is consistent in its approach to clients, regardless of their marital status
Pregnancy and maternity Positive The PGD’s does give alternative medication which can be issued
Race Positive The client needs are assessed on an individual basis and the approach to clients is regardless of their race
Religion or belief Positive The client wishes would be respected on an individual basis, privacy and dignity and respect are accounted for in the PGD
Sex Positive The medication within these PGD’s is available to both male and females
Sexual orientation Positive The PGD is consistent in its approach, regardless of sexual orientation
Disadvantaged groups Positive The service is open-access and medication is offered on an individual basis depending on tests

2.4 What positive impacts are there for this policy, service, strategy or event to better meet the needs of people with protected characteristics

The PGD’s are written for the needs of the clients who are being seen within the service. An assessment will be taken following the BASHH medical legibility criteria, which is produced by the to assess risk.

2.5 Is further work or consultation required?

No there is no further work or consultation required.

3 Authorisation

This equality impact assessment will need to be reviewed in line with any changes made to the policy, service, strategy, or event.

Lead authorisation
Detail Lead details
Name: Tina Proctor
Designation: Nurse consultant
Signature: Tina Proctor
Signature: 21 September 2021

Page last reviewed: September 23, 2024
Next review due: September 23, 2025

Problem with this page?

Please tell us about any problems you have found with this web page.

Report a problem